Date Filed | Type | Description |
01/31/2023 |
4
| Durso Jerome Benedict (President & CEO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 50,400 shares
@ $0 Granted 82,700 options to buy
@ $18.4, valued at
$1.5M
|
|
01/03/2023 |
4
| Durso Jerome Benedict (President & CEO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 7,083 shares
@ $12.37, valued at
$87.6k
|
|
01/31/2022 |
4
| Durso Jerome Benedict (President & CEO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 35,700 shares
@ $0 Granted 60,900 options to buy
@ $14.44, valued at
$879.4k
|
|
01/04/2022 |
4
| Durso Jerome Benedict (President & CEO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 5,607 shares
@ $16.29, valued at
$91.3k
Paid exercise price by delivering 334 shares
@ $16.29, valued at
$5.4k
|
|
10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2021 |
4
| Durso Jerome Benedict (President & CEO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 46,000 shares
@ $0 Granted 72,000 options to buy
@ $29.46, valued at
$2.1M
|
|
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/25/2020 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $35.47, valued at
$11.3k
|
|
10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/25/2020 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $48.21, valued at
$15.4k
|
|
07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2020 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $80.51, valued at
$25.7k
|
|
04/03/2020 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 289 shares
@ $58.4, valued at
$16.9k
|
|
02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/27/2020 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 10,600 shares
@ $0 Granted 17,400 options to buy
@ $99.66, valued at
$1.7M
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/26/2019 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 460 shares
@ $88.89, valued at
$40.9k
|
|
10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/27/2019 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $60.9, valued at
$19.4k
|
|
07/03/2019 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 289 shares
@ $79.17, valued at
$22.9k
|
|
05/28/2019 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 460 shares
@ $85.51, valued at
$39.3k
|
|
04/03/2019 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 289 shares
@ $111.5, valued at
$32.2k
|
|
02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2019 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 9,400 shares
@ $0 Granted 15,200 options to buy
@ $110.8, valued at
$1.7M
|
|
01/03/2019 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 1,219 shares
@ $100.79, valued at
$122.9k
|
|
11/27/2018 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 460 shares
@ $111.07, valued at
$51.1k
|
|
10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2018 |
4
| Durso Jerome Benedict (COO) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns:
| Granted 13,600 shares
@ $0 Granted 20,700 options to buy
@ $58.74, valued at
$1.2M
|
|
02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/27/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |